We looked inside some of the tweets by @MMKavanagh and here's what we found interesting.
Inside 100 Tweets
Quoted @povertyscholar
As an undergrad I worked 2-3 campus jobs at a time. Serving in the dining hall, delivering papers, RA work etc. It was one of the reasons I felt estranged from my campus peers—I was working so much more than them. If one of my jobs had paid well, it would have been a game changer https://t.co/afJ590lj3y
College services and research depend on those of us who work through college (I washed sweaty towels in the gym, RAed, stacked books in the library). Academics can pay $15/hr. https://t.co/qaFS8tBLqD
#COVID19 update in Africa as of 16/01/2021 at 6 PM EAT. Cases -- 3,211,141., Deaths – 77,720 and Recoveries --2,619,687. More at https://t.co/7xkrFH4etK #AfricaResponds #TestTraceTreat #FactsNotFear https://t.co/8gA93xrr4a
Quoted @MMKavanagh
Remarkable (appalling) spin on #COVID failure by @SecAzar: "If a novel virus like this emerged in a Democratic nation, this epidemic would have never happened" Trump admin practices "radical transparency" In February "no immediate threat" CDC thrown under bus. https://t.co/vomxm4r6Vo https://t.co/y18kBtNREp
Bringing that skill set into governing gets you this... 👇. Let’s not anymore? https://t.co/otAZiRFAbN
Quoted @peopleb4pharma
Gilead has a long history of price gouging Rx drugs, like Sovaldi that treats Hep C. Gilead’s monopoly control over the price isn’t b/c they discovered it. It’s b/c they used a merger to get research paid for by our tax $.Tell Gilead - no more price gouging #LowerDrugPricesNow
Execs have gotten very good at using intellectual property laws to exact high rents on knowledge they buy up from smaller companies (this the actual r&d costs are knowable, even if they’re kept secret) Eg 👇 https://t.co/Rz1vU42uVg
Meanwhile industry execs have done everything in their power to slip out from under 340B Drug Pricing Program requiring them to provide more affordable drugs for hospitals & clinics serving low income people ... https://t.co/lYpf1OQgkf
Quoted @Kidfears99
Eli Lilly conspired with its competitors to price fix BASIC INSULIN and increase the price from $21/vial to $275+/vial. One vial lasts me about a week and I die in 48-72 hours without it. You exploit our human need for insulin to line ur own pockets. You can’t fake morality. https://t.co/EK4kT7OsX4
Take insulin prices for example—Azar came from Lilly which has come up with all sorts of excuses for why it can/should/must hike insulin prices despite no innovation. The company has been hugely successful at misinformation, far less successful at public health or innovation 👇 https://t.co/QTgja0rjWY
Quoted @ProfLWiley
The Trump administration has been lying about how many vaccine doses the US has. Azar lied about a stockpile that does not exist while bullying states into opening up access to all over-65s ahead of schedule. https://t.co/vA7dbZu3Qr
A not-small take away from COVID crisis: top executives in Pharma incentivized to lie/not “know.” Hiring this one to run HHS? lies, spin + world’s largest COVID failure. 400k dead. Not being hyperbolic, this is a structural prob b/c of perverse industry & governance incentives 🧵 https://t.co/rznBPsvVYk
Quoted @alondra
Sound science will touch every aspect of what the Biden Administration does–from new policy, to addressing social inequality, to the implications of new technologies. As Deputy Director for Science and Society, inclusive and trustworthy science will have a place in government.
This is a super smart pick and a really interesting signal about science in the Biden-Harris admin. https://t.co/FZVUYPnC1P
The medicines system isn’t broken, it’s working like it was designed to. That’s the problem. @pritikrishtel knocked this out of the park. https://t.co/2suarhLYt2
Ok the grant is in--with a good 6 minutes to spare! So what's happening in the rest of the world? https://t.co/HSLghchOZK
Quoted @TAC
The TAC mourns the loss of Andrew Mosane, our former PLHIV sector rep. Our Chairperson @SibongileTsha14 said Com Andrew should be remembered "as a force. A selfless leader who advocated for the rights of PLHIV and broader Healthcare users in both official & unofficial capacities" https://t.co/6GfUfFCJuj
This is really a sad loss, rest in power Andrew https://t.co/RB3YP2us3G
Quoted @MMKavanagh
🚨Job, help spread the word🗣️ Our team @oneillinstitute is recruiting a new Program Coordinator--great job for someone who geeks out on coordination, admin, and light data work + excited about international politics, human rights, and global health https://t.co/DXf2ORvflW https://t.co/aNpcKb7bl7
re-upping this position--interviews starting, open until filled, fun team. Work w @lfnorato @udnore @mplngr @KashishAneja_ @kfginsbach https://t.co/DGKUb9FlGR
Quoted @AnantBhan
THE VACCINE DILEMMA The government has announced an intent to go ahead with vaccination as of 16th Jan 2021 with both Covishield and Covaxin. There is going to be no choice. You will only be able to receive one of the two, whatever is allotted to you by the govt.
Important and fascinating thread. India in uncharted territory, at least in recent history. #VaccinePolitics https://t.co/dVRPozg6nW
apparently needs saying: The US response to #COVID19 has been an epic failure. Plenty of reasons, but we have to start from there--there is no way to explain this giant blue circle as China's fault. Multiple points where it could have been reversed. This did not have to happen. https://t.co/bKrfrG1sOR https://t.co/wi1LFMeeaY
@KayColesJames @Heritage says that Sec Azar leaves a "wonderful legacy"--a breathtaking assessment of what is objectively the world's clearest and largest failure to respond effectively to #COVID19 https://t.co/BdO7KgHXHa
Remarkable (appalling) spin on #COVID failure by @SecAzar: "If a novel virus like this emerged in a Democratic nation, this epidemic would have never happened" Trump admin practices "radical transparency" In February "no immediate threat" CDC thrown under bus. https://t.co/vomxm4r6Vo https://t.co/y18kBtNREp
Increasingly, the expectation should be that PLHIV have CHOICE--empowered and encouraged to get HIV treatment where and how it works for them, and shift as their needs do. Anna Grimsrud @iasociety shows how @PEPFAR has embraced that in the new guidance https://t.co/FqYEk1hT58